AKBA 2.83 ▲ 1.43% Live Trading Data - Stocknear

Akebia Therapeutics Inc.

NASDAQ: AKBA · Real-Time Price · USD
2.83
0.04 (1.43%)
At close: Sep 23, 2025, 3:59 PM
1.43%
Bid 2.78
Market Cap 750.36M
Revenue (ttm) 203.73M
Net Income (ttm) -36.48M
EPS (ttm) -0.18
PE Ratio (ttm) -15.72
Forward PE 34.88
Analyst Buy
Dividends n/a
Ask 2.89
Volume 2,180,253
Avg. Volume (20D) 3,888,573
Open 2.79
Previous Close 2.79
Day's Range 2.78 - 2.90
52-Week Range 1.24 - 4.08
Beta 1.02
Ex-Dividend Date n/a

About AKBA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKBA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AKBA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Akebia Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-20.58%
Akebia Therapeutics shares are trading lower follo... Unlock content with Pro Subscription
4 months ago
+6.5%
Akebia Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.